CRYBA1 抗体 (N-Term)
Quick Overview for CRYBA1 抗体 (N-Term) (ABIN6743616)
抗原
See all CRYBA1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- N-Term
-
特异性
- Human CRYBA1
-
预测反应
- Percent identity by BLAST analysis: Mouse, Rat, Dog, Bovine, Guinea pig (100%) Chicken, Xenopus (92%) Zebrafish (85%).
-
纯化方法
- Immunoaffinity purified
-
免疫原
-
Synthetic peptide from N-Terminus of human CRYBA1 (P05813, NP_005199). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Galago, Marmoset, Mouse, Rat, Elephant, Panda, Dog, Bovine, Bat, Rabbit, Horse, Pig, Guinea pig (100%), Opossum, Zebra finch, Chicken, Xenopus, Frog, Salmon (92%), Zebrafish (85%), Turkey (83%).
Type of Immunogen: Synthetic peptide
-
-
anti-Crystallin, beta A1 (CRYBA1) (AA 1-215) antibody
CRYBA1 适用: 人 WB, ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Crystallin, beta A1 (CRYBA1) (AA 1-215) antibodyCRYBA1 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Crystallin, beta A1 (CRYBA1) (AA 104-133) antibodyCRYBA1 适用: 人, 小鼠 WB, IHC (p) 宿主: 兔 Polyclonal RB31287 unconjugated
anti-Crystallin, beta A1 (CRYBA1) (AA 111-141), (Middle Region) antibodyCRYBA1 适用: 人, 小鼠 WB, IHC (p), EIA 宿主: 兔 Polyclonal unconjugated
anti-Crystallin, beta A1 (CRYBA1) (AA 116-215) antibodyCRYBA1 适用: 人 WB, ELISA 宿主: 小鼠 Polyclonal unconjugated
anti-Crystallin, beta A1 (CRYBA1) (N-Term) antibodyCRYBA1 适用: 人, 小鼠, 大鼠 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Distilled water
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS with 2 % sucrose
-
注意事项
- Avoid repeat freeze-thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
